Cargando…

A study of ventilator-associated pneumonia: Incidence, outcome, risk factors and measures to be taken for prevention

Ventilator-associated pneumonia (VAP) is a major cause of hospital morbidity and mortality despite recent advances in diagnosis and accuracy of management. However, as taught in medical science, prevention is better than cure is probably more appropriate as concerned to VAP because of the fact that...

Descripción completa

Detalles Bibliográficos
Autores principales: Gadani, Hina, Vyas, Arun, Kar, Akhya Kumar
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016574/
https://www.ncbi.nlm.nih.gov/pubmed/21224971
http://dx.doi.org/10.4103/0019-5049.72643
_version_ 1782195776295796736
author Gadani, Hina
Vyas, Arun
Kar, Akhya Kumar
author_facet Gadani, Hina
Vyas, Arun
Kar, Akhya Kumar
author_sort Gadani, Hina
collection PubMed
description Ventilator-associated pneumonia (VAP) is a major cause of hospital morbidity and mortality despite recent advances in diagnosis and accuracy of management. However, as taught in medical science, prevention is better than cure is probably more appropriate as concerned to VAP because of the fact that it is a well preventable disease and a proper approach decreases the hospital stay, cost, morbidity and mortality. The aim of the study is to critically review the incidence and outcome, identify various risk factors and conclude specific measures that should be undertaken to prevent VAP. We studied 100 patients randomly, kept on ventilatory support for more than 48 h. After excluding those who developed pneumonia within 48 h, VAP was diagnosed when a score of ≥6 was obtained in the clinical pulmonary infection scoring system having six variables and a maximum score of 12. After evaluating, the data were subjected to univariate analysis using the chi-square test. The level of significance was set at P<0.05. It was found that 37 patients developed VAP. The risk factor significantly associated with VAP in our study was found to be duration of ventilator support, reintubation, supine position, advanced age and altered consciousness. Declining ratio of partial pressure to inspired fraction of oxygen (PaO(2)/FiO(2) ratio) was found to be the earliest indicator of VAP. The most common organism isolated in our institution was Pseudomonas. The incidence of early-onset VAP (within 96 h) was found to be 27% while the late-onset type (>96 h) was 73%. Late-onset VAP had poor prognosis in terms of mortality (66%) as compared to the early-onset type (20%). The mortality of patients of the non-VAP group was found to be 41% while that of VAP patients was 54%. Targeted strategies aimed at preventing VAP should be implemented to improve patient outcome and reduce length of intensive care unit stay and costs. Above all, everyone of the critical care unit should understand the factors that place the patients at risk of VAP and utmost importance must be given to prevent VAP.
format Text
id pubmed-3016574
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-30165742011-01-11 A study of ventilator-associated pneumonia: Incidence, outcome, risk factors and measures to be taken for prevention Gadani, Hina Vyas, Arun Kar, Akhya Kumar Indian J Anaesth Clinical Investigation Ventilator-associated pneumonia (VAP) is a major cause of hospital morbidity and mortality despite recent advances in diagnosis and accuracy of management. However, as taught in medical science, prevention is better than cure is probably more appropriate as concerned to VAP because of the fact that it is a well preventable disease and a proper approach decreases the hospital stay, cost, morbidity and mortality. The aim of the study is to critically review the incidence and outcome, identify various risk factors and conclude specific measures that should be undertaken to prevent VAP. We studied 100 patients randomly, kept on ventilatory support for more than 48 h. After excluding those who developed pneumonia within 48 h, VAP was diagnosed when a score of ≥6 was obtained in the clinical pulmonary infection scoring system having six variables and a maximum score of 12. After evaluating, the data were subjected to univariate analysis using the chi-square test. The level of significance was set at P<0.05. It was found that 37 patients developed VAP. The risk factor significantly associated with VAP in our study was found to be duration of ventilator support, reintubation, supine position, advanced age and altered consciousness. Declining ratio of partial pressure to inspired fraction of oxygen (PaO(2)/FiO(2) ratio) was found to be the earliest indicator of VAP. The most common organism isolated in our institution was Pseudomonas. The incidence of early-onset VAP (within 96 h) was found to be 27% while the late-onset type (>96 h) was 73%. Late-onset VAP had poor prognosis in terms of mortality (66%) as compared to the early-onset type (20%). The mortality of patients of the non-VAP group was found to be 41% while that of VAP patients was 54%. Targeted strategies aimed at preventing VAP should be implemented to improve patient outcome and reduce length of intensive care unit stay and costs. Above all, everyone of the critical care unit should understand the factors that place the patients at risk of VAP and utmost importance must be given to prevent VAP. Medknow Publications 2010 /pmc/articles/PMC3016574/ /pubmed/21224971 http://dx.doi.org/10.4103/0019-5049.72643 Text en © Indian Journal of Anaesthesia http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Investigation
Gadani, Hina
Vyas, Arun
Kar, Akhya Kumar
A study of ventilator-associated pneumonia: Incidence, outcome, risk factors and measures to be taken for prevention
title A study of ventilator-associated pneumonia: Incidence, outcome, risk factors and measures to be taken for prevention
title_full A study of ventilator-associated pneumonia: Incidence, outcome, risk factors and measures to be taken for prevention
title_fullStr A study of ventilator-associated pneumonia: Incidence, outcome, risk factors and measures to be taken for prevention
title_full_unstemmed A study of ventilator-associated pneumonia: Incidence, outcome, risk factors and measures to be taken for prevention
title_short A study of ventilator-associated pneumonia: Incidence, outcome, risk factors and measures to be taken for prevention
title_sort study of ventilator-associated pneumonia: incidence, outcome, risk factors and measures to be taken for prevention
topic Clinical Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016574/
https://www.ncbi.nlm.nih.gov/pubmed/21224971
http://dx.doi.org/10.4103/0019-5049.72643
work_keys_str_mv AT gadanihina astudyofventilatorassociatedpneumoniaincidenceoutcomeriskfactorsandmeasurestobetakenforprevention
AT vyasarun astudyofventilatorassociatedpneumoniaincidenceoutcomeriskfactorsandmeasurestobetakenforprevention
AT karakhyakumar astudyofventilatorassociatedpneumoniaincidenceoutcomeriskfactorsandmeasurestobetakenforprevention
AT gadanihina studyofventilatorassociatedpneumoniaincidenceoutcomeriskfactorsandmeasurestobetakenforprevention
AT vyasarun studyofventilatorassociatedpneumoniaincidenceoutcomeriskfactorsandmeasurestobetakenforprevention
AT karakhyakumar studyofventilatorassociatedpneumoniaincidenceoutcomeriskfactorsandmeasurestobetakenforprevention